Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher
Friendswood, Texas, U.S., September 28, 2026 Castle Biosciences has announced new clinical evidence demonstrating how its TissueCypher® Barrett’s Esophagus...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Friendswood, Texas, U.S., September 28, 2026 Castle Biosciences has announced new clinical evidence demonstrating how its TissueCypher® Barrett’s Esophagus...
BOONE, N.C., July 20, 2026 Fuse Oncology has unveiled FuseRx, an innovative AI-powered prescribing and treatment-intent solution designed to...
MINNEAPOLIS, Minn., July 14, 2026 Celcuity Inc. has achieved a major regulatory milestone after the U.S. Food and Drug...
SANTA CLARA, Calif., July 14, 2026 Autonomous Healthcare has achieved a landmark regulatory milestone after the U.S. Food and...
BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
AMSTERDAM, Netherlands, June 9, 2026 Artificial intelligence is already delivering measurable benefits across healthcare systems, saving clinicians the equivalent...
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
